People
Ash Khanna
Ash Khanna is Chief Business Officer of Tentarix Biotherapeutics, appointed in September2025, following a partner role at Pivotal bioVenture Partners. His career includes co-founding Vaxcyte and leading its business development and financing activities, venture investing at SV Health Investors and scientific work at Bristol Myers Squibb. He has a pharmacology PhD from SUNY Buffalo and a Wharton MBA and contributed to the invention of saxagliptin/Onglyza. Arkuda’s archived2023 company roster names him as a board member with a contemporaneous Pivotal title; that affiliation is historical and does not establish current Arkuda board membership or a personal investment.
Roles
Board Member (archived company roster; historical, current status unverified)